Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
Price Target
Average
61.25%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
25.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Trevi Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TRVI of $7.2 , with forecasts ranging from
a
low of
$6 to a high of $12 .
TRVI Lowest Price Target
Wall Street Target
6 USD
34.38%
TRVI Average Price Target
Wall Street Target
7.2 USD
61.25%
TRVI Highest Price Target
Wall Street Target
12 USD
168.76%
REVENUE FORECAST
Revenue Forecast Chart TRVI
EBIT FORECAST
EBIT Forecast Chart TRVI
NET INCOME FORECAST
Net Income Chart TRVI